Johnson & Johnson's Revenue by Region
In fiscal year 2024, Johnson & Johnson's revenue by geographical region are as follows:
- Asia-Pacific, Africa: $13.59 B
- Europe: $20.21 B
- United States: $50.30 B
- Western Hemisphere excluding United States: $4.71 B
Learn more about Johnson & Johnson’s Revenue by Products
Check out competitors to Johnson & Johnson in a side-by-side comparison.
Explore additional financial metrics for Johnson & Johnson.
| Asia-Pacific, Africa | 17275000000 |
|---|---|
| Europe | 23594000000 |
| UNITED STATES | 47156000000 |
| Western Hemisphere, excluding U.S. | 5750000000 |
| Asia-Pacific, Africa | 13756000000 |
|---|---|
| Europe | 20410000000 |
| United States | 46444000000 |
| Western Hemisphere excluding United States | 4549000000 |
| Asia-Pacific, Africa | 13593000000 |
|---|---|
| Europe | 20212000000 |
| United States | 50302000000 |
| Western Hemisphere excluding United States | 4714000000 |
The above chart shows Johnson & Johnson's revenue percentage share by geographical region.
In fiscal year 2022, Johnson & Johnson's revenue by region is as follows:
- Asia-Pacific, Africa generated $17.28 B in revenue, representing 18.42% of its total revenue.
- Europe generated $23.59 B in revenue, representing 25.16% of its total revenue.
- UNITED STATES generated $47.16 B in revenue, representing 50.29% of its total revenue.
- Western Hemisphere, excluding U.S. generated $5.75 B in revenue, representing 6.13% of its total revenue.
The biggest region for Johnson & Johnson is the UNITED STATES, which represents 50.29% of its total revenue.
The smallest region for Johnson & Johnson is the Western Hemisphere, excluding U.S., which represents 6.13% of its total revenue.
The above chart shows Johnson & Johnson's revenue percentage share by geographical region.
In fiscal year 2023, Johnson & Johnson's revenue by region is as follows:
- Asia-Pacific, Africa generated $13.76 B in revenue, representing 16.15% of its total revenue.
- Europe generated $20.41 B in revenue, representing 23.97% of its total revenue.
- United States generated $46.44 B in revenue, representing 54.54% of its total revenue.
- Western Hemisphere excluding United States generated $4.55 B in revenue, representing 5.34% of its total revenue.
The biggest region for Johnson & Johnson is the United States, which represents 54.54% of its total revenue.
The smallest region for Johnson & Johnson is the Western Hemisphere excluding United States, which represents 5.34% of its total revenue.
The above chart shows Johnson & Johnson's revenue percentage share by geographical region.
In fiscal year 2024, Johnson & Johnson's revenue by region is as follows:
- Asia-Pacific, Africa generated $13.59 B in revenue, representing 15.3% of its total revenue.
- Europe generated $20.21 B in revenue, representing 22.76% of its total revenue.
- United States generated $50.30 B in revenue, representing 56.63% of its total revenue.
- Western Hemisphere excluding United States generated $4.71 B in revenue, representing 5.31% of its total revenue.
The biggest region for Johnson & Johnson is the United States, which represents 56.63% of its total revenue.
The smallest region for Johnson & Johnson is the Western Hemisphere excluding United States, which represents 5.31% of its total revenue.
Summary Table
| Geography (Percent Share) | 2022 | 2023 | 2024 |
|---|---|---|---|
| Asia-Pacific, Africa | 18.42% | 16.15% | 15.3% |
| Europe | 25.16% | 23.97% | 22.76% |
| UNITED STATES | 50.29% | 0% | 0% |
| United States | 0% | 54.54% | 56.63% |
| Western Hemisphere excluding United States | 0% | 5.34% | 5.31% |
| Western Hemisphere, excluding U.S. | 6.13% | 0% | 0% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of Johnson & Johnson.
In fiscal year 2024, the United States generated the most revenue ($50.30 B), and the Western Hemisphere excluding United States generated the least revenue ($4.71 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Region | 2022 | 2023 | 2024 |
|---|---|---|---|
| Asia-Pacific, Africa | $17.28 B - |
$13.76 B
20.37%
|
$13.59 B
1.18%
|
| Europe | $23.59 B - |
$20.41 B
13.49%
|
$20.21 B
0.97%
|
| UNITED STATES | $47.16 B - | - - | - - |
| United States | - - | $46.44 B - |
$50.30 B
8.31%
|
| Western Hemisphere excluding United States | - - | $4.55 B - |
$4.71 B
3.63%
|
| Western Hemisphere, excluding U.S. | $5.75 B - | - - | - - |
| Total Revenue | $93.78 B - |
$85.16 B
9.19%
|
$88.82 B
4.30%
|
Related
-
Agilent Technologies Revenue by Region
-
Eli Lilly and Company Revenue by Region
-
Stryker Corporation Revenue by Region
-
AbbVie Revenue by Region
-
Merck & Co. Revenue by Region
-
Thermo Fisher Scientific Revenue by Region
-
Abbott Laboratories Revenue by Region
-
Danaher Corporation Revenue by Region
-
Amgen Revenue by Region
-
Pfizer Revenue by Region
